Comparison of extended-release niacin and atorvastatin monotherapies and combination treatment of the atherogenic lipid profile in diabetes mellitus.
Van
Joanne T
JT
Diabetes Research Center, Tustin, California 92780, USA.
Pan
Jianqiu
J
Wasty
Talat
T
Chan
Eve
E
Wu
Xiaoshan
X
Charles
M Arthur
MA
D000069059:Atorvastatin; D002784:Cholesterol / Q000097:blood; D003692:Delayed-Action Preparations; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006538:Heptanoic Acids / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D000960:Hypolipidemic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D009525:Niacin / Q000494:pharmacology / Q000627:therapeutic use*; D011758:Pyrroles / Q000494:pharmacology / Q000627:therapeutic use*; D012189:Retrospective Studies; D014280:Triglycerides / Q000097:blood
D003692:Delayed-Action Preparations; D006538:Heptanoic Acids; D000960:Hypolipidemic Agents; D011758:Pyrroles; D014280:Triglycerides; D009525:Niacin; D002784:Cholesterol; D000069059:Atorvastatin